• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Gudjon_Iceland

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Replies Created

Viewing 1 post (of 1 total)
  • Author
    Posts
  • September 29, 2016 at 10:06 pm in reply to: Newcomer #2167
    Gudjon_Iceland
    Participant

      Greetings to you as well my dear friends from Turkey and around the world.

    • Author
      Posts
    Viewing 1 post (of 1 total)

    Primary Sidebar

    Advocacy

    • Advocacy Toolkit

    Approved Drugs

    • Nuedexta
    • Radicava/Edaravone
    • Riluzole/Tiglutik
    • Rozebalamin / Methylcobalamin
    • Tofersen/Qalsody

    Drugs in Development

    • AB Science – Masitinib
    • NurOwn
    • Clene Nanomedicine – CNM-Au8
    • ILB
    • Kadimastem – AstroRx
    • Neuronata-R / Lenzumestrocel
    • NeuroSense – PrimeC
    • NP001
    • Prilenia Therapeutics – Pridopidine
    • SOD1 Therapies & Trials
    • SPG302
    • Regulatory T Cell Enhancing Therapies
    • Ulefnersen

    Care services

    • Genetic Counselling & Testing
    • Mental Health Support
    • Nursing and Symptom Management
    • Nutrition, Swallowing and Saliva
    • Activities of Daily Living and Occupational Therapy
    • Muscles, Mobility and Exercise
    • Respiratory Care
    • Speech and Communication
    • Support for Family & Caregivers
    • Technology

    Support for members

    • Alliance Support Grant
    • About the meetings

    Programs & Events

    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • International Symposium

    About

    • Who We Are
    • Board of Trustees
    • Councils, Forums & Committees
      • PALS and CALS Advisory Council
      • Scientific Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
      • Meetings
    • Awards

    Upcoming Events

    Nov 2
    2:00 pm - 3:00 pm EST

    ALS Association Webinar: Caregiving, Connection & Meaningful Moments Series

    Nov 3
    2:00 pm - 3:00 pm EST

    ALS Association Webinar: Caregiving, Connection & Meaningful Moments Series

    Nov 4
    8:00 am - 9:00 am EST

    Webinar: Annual Clinical Trials Update

    Nov 4
    2:00 pm - 3:00 pm EST

    ALS Association Webinar: Caregiving, Connection & Meaningful Moments Series Copy Copy

    Nov 6
    November 6 @ 12:30 pm - November 7 @ 6:00 pm CET

    Neuroscience Institute Cavalieri Ottolenghi, University of Turin: Motor Neuron Diseases 2026 – IV Edition

    View Calendar

    • Jay Epstein, USA

      Jay Epstein, USA

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Kris Van Reusel, Belgium

      Kris Van Reusel, Belgium

    • Lee Millard, England

      Lee Millard, England

    • Jose Rivero Muñoz, Mexico

      Jose Rivero Muñoz, Mexico

    • Valdomiro Xavier Honório, Brazil

      Valdomiro Xavier Honório, Brazil

    • Teddy Hanono Annie, Mexico

      Teddy Hanono Annie, Mexico

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Dawn Morton, Scotland

      Dawn Morton, Scotland

    • Mirca Bersani, Italy

      Mirca Bersani, Italy
      MircaBersani

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Greg Heydet, USA

      Greg Heydet, USA

    • Angie Bordaen, Belgium

      Angie Bordaen, Belgium

    • John Dinon, Australia

      John Dinon, Australia

    • Rosie Riley, USA

      Rosie Riley, USA

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • David Solomon, UK

      David Solomon, UK

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Alfredo Santos, Colombia

      Alfredo Santos, Colombia

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • Duncan Bayly, Australia

      Duncan Bayly, Australia

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Shera Mukherjee, India

      Shera Mukherjee, India

    • David Watson, Scotland

      David Watson, Scotland

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Anita Forte, USA

      Anita Forte, USA

    • Marcel R. Wernard, Netherlands

      Marcel R. Wernard, Netherlands

    • Margarita Pizarro, Argentina

      Margarita Pizarro, Argentina

    • Alberto Baez Murillo, Colombia

      Alberto Baez Murillo, Colombia

    • Lachlan Terry, Australia

      Lachlan Terry, Australia

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Zabun Nassar, England

      Zabun Nassar, England

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Sally Pauls, USA

      Sally Pauls, USA

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Olga, Argentina

      Olga, Argentina

    • Glen Elison, USA

      Glen Elison, USA

    • Eddy Lefrancois, Canada

      Eddy Lefrancois, Canada

    • Jorge Luis Fernández Romero, Mexico

      Jorge Luis Fernández Romero, Mexico

    • Bob Simonds, USA

      Bob Simonds, USA

    • Hollister

      Hollister
      hollister

    Learn more about the March of Faces

    Coronavirus (COVID-19) Resources

    Instructions

    First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

    If you have already registered, please use the details provided to log in using this form.

    Drugs No Longer in Development

    • AMX0035
    • Reldesemtiv
    • Arimoclomol
    • TUDCA

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login